Engage 7 mm bone-level implant

OCO Biomedical Inc., a proven global leader in implant dentistry products, technology and training, recently introduced its Engage 7 mm bone-level implant, the latest addition to the company’s extensive product line.

According to Dr. Charles Schlesinger, OCO Biomedical’s chief operating officer and director of education and clinical affairs: “With the addition of the 7 mm to our Engage product line, practitioners have yet another advantage when treatment plans call for immediate and selective load, bone-level implants. With the combination of our patented Bull Nose Auger tip and Mini Cortic-O thread, the Engage implant system offers unchallenged stability, which is particularly important when placement is needed in the anterior or posterior mandible/maxilla.

“To further enable practitioners to provide the best care possible in the shortest amount of time, we also offer the Engage Prosthetic Package, which includes easy-to-follow protocols and procedures and can incorporate the full Engage product line.”

“We strive to provide the best education possible for implant dentists, at all levels of experience and complexity,” Schlesinger said. “‘The OCO Advantage’ offers the foundation for improving patient care and building practice performance. OCO’s clinically proven products and training programs continue to be well-received nationwide.”

“Clear evidence of this is the increased participation in our educational courses, seminars and the number of early registrants we’ve received for our OCO 2015 International Dental Implant Symposium.”

About OCO Biomedical

Established in 1977 and headquartered in Albuquerque, N.M., OCO Biomedical Inc. is a privately owned dental implant company. In addition to the company’s vast network of practitioners using OCO products in the United States, the company has an international network of distributors located in Asia, Central and South America, Europe and the Caribbean.